Why CBD Oils Are Now Classified as Chemical Products in Switzerland

The CBD market is evolving rapidly in Switzerland. At La Salade CBD, we have always chosen transparency, compliance, and customer safety as our top priorities. Today, certain CBD oils sold in Switzerland are officially classified as chemical products by federal authorities.

This decision may seem surprising, but it is based on a clear regulatory framework designed to protect consumers. In this article, we explain why CBD oils are affected, what this means in practice, and why we choose a responsible communication approach without therapeutic claims, misleading advertising, or minimizing risks.

Why are certain CBD oils classified as chemical products?

In March 2022, the Swiss Notification Authority for Chemicals published an official decision regarding CBD-containing scented oils.

According to this decision, CBD oils marketed outside the food or therapeutic categories may fall under Swiss chemical legislation. The authorities consider that these products could be consumed orally, even when presented as scented oils.

The document also specifies that these oils do not fall under therapeutic products law or food legislation when marketed in this form. As a result, certain CBD oils must now be marketed in accordance with the regulations applicable to chemical products.

A decision aimed at protecting consumers

Swiss authorities explain that CBD is often associated with relaxing or anti-inflammatory effects, which may encourage inappropriate use of these products.

The main concern is that consumers may orally ingest oils marketed as chemical products, thereby bypassing the strict requirements that apply to medicines or food products.

For this reason, Switzerland now requires certain safety measures, including the addition of denaturing agents to discourage abusive oral consumption.

This regulation does not mean that CBD is banned. It simply regulates how certain products may be marketed.

Why we make no therapeutic claims

At La Salade CBD, we strictly comply with Swiss regulations.

Our CBD oils are not sold as medicines, and we never claim that they can treat, prevent, or cure any disease.

Therapeutic claims may cause a product to be classified as a medicinal product, requiring a specific authorization. That is why we focus on honest and responsible communication.

• We describe our products without medical promises.
• We avoid exaggerated claims.
• We never minimize the potential risks associated with improper use.
• We always encourage responsible use in compliance with legal requirements.

Responsible and transparent communication

The CBD industry still suffers from misleading or exaggerated marketing messages. Some brands promise spectacular effects without recognized scientific evidence.

At La Salade CBD, we take a different approach. We believe consumers should be able to choose their products based on clear, compliant, and honest information.

No misleading advertising

We do not present CBD as a miracle solution.

No medical promises

Our products are not intended to replace medical treatment or professional healthcare advice.

No minimization of risks

Like any regulated product, CBD should be used responsibly and according to legal guidelines.

What does this mean for consumers?

For Swiss consumers, this regulatory evolution mainly means improved market supervision and a clearer distinction between therapeutic products, food products, and chemical products.

• Better regulation of the Swiss CBD market.
• Stronger requirements regarding labeling and safety.
• Clearer distinction between therapeutic, edible, and chemical CBD products.
• Easier identification of compliant and trustworthy brands.

Our commitment at La Salade CBD

From the very beginning, La Salade CBD has been committed to high-quality, traceable, and compliant CBD products.

We closely follow legal developments to ensure compliant products, full transparency, responsible communication, and consumer protection.

The CBD market continues to evolve, and we will continue to prioritize quality, safety, and trust.

Official source

General decision issued by the Swiss Notification Authority for Chemicals regarding the marketing of CBD-containing scented oils, published on March 29, 2022.